Fox Chase Cancer Center Clinical Director Wins Oncology Nursing Society’s Excellence in Cancer Nursing Management Award

Erin Longstreth
Erin Longstreth-Papsun, RN, MSN, OCN, NEA-BC, was recently awarded the Excellence in Cancer Nursing Management Award by the Oncology Nursing Society (ONS).

PHILADELPHIA (April 11, 2023)—Erin Longstreth-Papsun, RN, MSN, OCN, NEA-BC, clinical director of Ambulatory Satellite Clinics and Radiation Oncology Nursing at Fox Chase Cancer Center, was recently awarded the Excellence in Cancer Nursing Management Award by the Oncology Nursing Society (ONS).

“Being nominated for this award is a humbling experience and has given me the opportunity to reflect on my career thus far, see how much progress I have made, and to realign my goals for the next five years,” said Longstreth-Papsun. “I have learned that nursing leadership is a journey, a dynamic process of continuous development through which there is always more to learn and do.”

The award is presented to a nurse manager or administrator with proven excellence in their field. To be considered for it, nominees must be an active ONS member with at least two years of experience in oncology nursing management or administration. Additionally, they must display exemplary leadership abilities and have support from supervisors.

“To have Erin honored with this award speaks volumes about her leadership skills and about the level of nursing at Fox Chase in general,” said Anna Rodriguez, MSN, MHA, RN, OCN, NEA-BC, Chief Nursing Officer and Vice President of Nursing and Patient Services at Fox Chase.

“Erin is a most worthy candidate to receive this honor,” said Kathleen Wolf, director of Magnet/Nursing Quality at Fox Chase. “A special trait Erin displays in her leadership is her ongoing recognition of her staff. She holds her team accountable to high standards of care, they deliver, and Erin celebrates her team.”

Longstreth-Papsun has been a nurse leader at Fox Chase for 17 years. She began her career as a bedside nurse, later becoming a supervisor and clinical manager and immersing herself in various projects and opportunities to lead change and highlight the work of Fox Chase.

Early on in her career, she participated in a research publication about caring for autistic oncology patients after surgery and formed a team which was chosen to participate in the second cohort of the American Academy of Critical Care Nurses Clinical Scene Investigator Academy program. This experience led her to help develop a project focused on decreasing hospital stay and drug use for patients experiencing delirium, which resulted in a projected annual impact of $766,500.

Additionally, she led a team involved in a National Institutes of Health grant program through the City of Hope educating nurses about geriatric oncology care. Through this, she helped create a project focused on enhanced support and assessment of the geriatric oncology population.

“Being honored by this award, I felt compelled to get more involved with leadership in oncology nursing at a larger scale, so I ran for president-elect for the local Oncology Nursing Society chapter and was elected in February,” said Longstreth-Papsun. “I am very excited to play a role in moving our profession forward and hope to continue my growth in this role and maybe one day lead at a national level.”

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427